Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Heart Failure|June 22, 2012
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and designStefano Ghio, Diana Bonderman, Stephan B Felix, et al.Circulation. Heart Failure|April 11, 2013
Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular functionNeal A Chatterjee, Ryan M Murphy, Rajeev Malhotra, et al.Circulation. Heart Failure|March 19, 2015
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fractionBarry A Borlaug, Gregory D Lewis, Steven E McNulty, et al.Nature Clinical Practice. Cardiovascular Medicine|February 24, 2009
Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human heartsNezam Haider, Eloisa Arbustini, Sudhir Gupta, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 11, 2011
Relationship of right- and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysisMark H Drazner, Robert N Brown, Patricia A Kaiser, et al.JACC. Heart Failure|October 17, 2016
Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX TrialParul U Gandhi, Hanna K Gaggin, Margaret M Redfield, et al.Circulation|June 19, 2013
Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic studyDiana Bonderman, Stefano Ghio, Stephan B Felix, et al.Circulation. Heart Failure|May 17, 2014
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studySelma F Mohammed, Barry A Borlaug, Steven McNulty, et al.Journal of Cardiac Failure|August 4, 2012
Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) studyHanna K Gaggin, Asim A Mohammed, Anju Bhardwaj, et al.Circulation|September 6, 2007
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertensionGregory D Lewis, Ravi Shah, Khurram Shahzad, et al.Pageof 8